Results 31 to 40 of about 20,804,255 (278)

NDUFAF6-Related Leigh Syndrome Caused by Rare Pathogenic Variants: A Case Report and the Focused Review of Literature

open access: yesFrontiers in Pediatrics, 2022
Leigh syndrome is a neurodegenerative disorder that presents with fluctuation and stepwise deterioration, such as neurodevelopmental delay and regression, dysarthria, dysphagia, hypotonia, dystonia, tremor, spasticity, epilepsy, and respiratory problems.
Jaewon Kim, Jaewoong Lee, Dae-Hyun Jang
doaj   +1 more source

A General Synopsis of Birds

open access: yes
Vorlage des Erscheinungsvermerks: London: Printed for Leigh & Sotheby, York Street, Covent Garden. MDCCLXXXV.16 Ill. (kolor. Kupferst.
Latham, John
core   +4 more sources

Mutations in SURF1 are important genetic causes of Leigh syndrome in Slovak patients

open access: yesEndocrine Regulations, 2018
Objectives. Leigh syndrome is a progressive early onset neurodegenerative disease typically presenting with psychomotor regression, signs of brainstem and/or basal ganglia disease, lactic acidosis, and characteristic magnetic resonance imaging findings ...
Danis Daniel   +7 more
doaj   +1 more source

Peripheral macrophages drive CNS disease in the Ndufs4(−/−) model of Leigh syndrome

open access: yesBrain Pathology, 2023
Subacute necrotizing encephalopathy, or Leigh syndrome (LS), is the most common pediatric presentation of genetic mitochondrial disease. LS is a multi‐system disorder with severe neurologic, metabolic, and musculoskeletal symptoms.
Allison R. Hanaford   +13 more
semanticscholar   +1 more source

Exploring mTOR inhibition as treatment for mitochondrial disease

open access: yesAnnals of Clinical and Translational Neurology, 2019
Leigh syndrome and MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke‐like episodes) are two of the most frequent pediatric mitochondrial diseases. Both cause severe morbidity and neither have effective treatment.
Abigail Sage‐Schwaede   +6 more
doaj   +1 more source

Epilepsy in Leigh Syndrome With Mitochondrial DNA Mutations

open access: yesFrontiers in Neurology, 2019
Background: Leigh syndrome is a mitochondrial cytopathy that presents as a neurodegenerative disease with apparent manifestation in the central nervous system.
Sunho Lee   +3 more
doaj   +1 more source

Mitochondrial Oxidative Stress Mediates Bradyarrhythmia in Leigh Syndrome Mitochondrial Disease Mice

open access: yesAntioxidants, 2023
Mitochondrial oxidative stress has been implicated in aging and several cardiovascular diseases, including heart failure and cardiomyopathy, ventricular tachycardia, and atrial fibrillation.
Bi-Yi Chen   +4 more
semanticscholar   +1 more source

Volatile anaesthetic toxicity in the genetic mitochondrial disease Leigh syndrome

open access: yesBritish Journal of Anaesthesia, 2023
Background Volatile anaesthetics are widely used in human medicine. Although generally safe, hypersensitivity and toxicity can occur in rare cases, such as in certain genetic disorders.
Kira A. Spencer   +8 more
semanticscholar   +1 more source

Self-replicative mRNA-mediated generation of induced pluripotent stem cell line from a 1-year-old Leigh syndrome patient with mitochondrial DNA cytochrome b mutation

open access: yesStem Cell Research, 2021
Leigh syndrome is a progressive neurodegenerative disease due to defects in the mitochondrial genes, including mitochondrial DNA cytochrome b (MTCYB) mutation, that typically begins in infancy or early childhood.
Daryeon Son   +3 more
doaj   +1 more source

Leukocytes mediate disease pathogenesis in the Ndufs4(KO) mouse model of Leigh syndrome

open access: yesJCI Insight, 2022
Symmetric, progressive, necrotizing lesions in the brainstem are a defining feature of Leigh syndrome (LS). A mechanistic understanding of the pathogenesis of these lesions has been elusive.
Julia C. Stokes   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy